Abstract
Diabetic and endocrine emergencies are traditionally treated by the acute medical admitting team or accident and emergency department staff. Most will see diabetic emergencies on a regular basis, as they are common and both type 1 and type 2 disease are increasing in prevalence. Diabetic emergencies are usually easily treated and the patients discharged. However, it is vital not to become complacent as these disorders can lead to death. It is particularly important to follow local guidance and to involve the diabetes team both during and after each episode. Recently it has become clear that about 30% of patients admitted with acute coronary syndrome (including infarction) have either diabetes or "stress hyperglycaemia"; evidence suggests that these patients should be treated not only as a cardiac emergency but also as a diabetic one. Thus, every patient with acute coronary syndrome or acute myocardial infarction needs diabetes to be excluded. The other endocrine emergencies are less common, but in some ways more important simply because of their rarity. A high level of suspicion is often required to make a diagnosis, although some, such as myxoedema coma, are usually obvious. Treatment must be started before the diagnosis can be confirmed. Guidance on making the diagnosis and initiating treatment should be made available on the local NHS intranet for non-endocrinologists to access; and where possible expert advice made available by telephone. The basic management steps in the common diabetic and endocrine emergencies are outlined; this is not a complete list, but rather an insight for those involved in non-selected emergency admissions.
Full Text
The Full Text of this article is available as a PDF (98.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Glaser N., Barnett P., McCaslin I., Nelson D., Trainor J., Louie J., Kaufman F., Quayle K., Roback M., Malley R. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001 Jan 25;344(4):264–269. doi: 10.1056/NEJM200101253440404. [DOI] [PubMed] [Google Scholar]
- Guerci Bruno, Benichou Muriel, Floriot Michèle, Bohme Philip, Fougnot Sebastien, Franck Patricia, Drouin Pierre. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care. 2003 Apr;26(4):1137–1141. doi: 10.2337/diacare.26.4.1137. [DOI] [PubMed] [Google Scholar]
- Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997 May 24;314(7093):1512–1515. doi: 10.1136/bmj.314.7093.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morris L. R., Murphy M. B., Kitabchi A. E. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986 Dec;105(6):836–840. doi: 10.7326/0003-4819-105-6-836. [DOI] [PubMed] [Google Scholar]
- Piniés J. A., Cairo G., Gaztambide S., Vazquez J. A. Course and prognosis of 132 patients with diabetic non ketotic hyperosmolar state. Diabete Metab. 1994 Jan-Feb;20(1):43–48. [PubMed] [Google Scholar]
- Randeva H. S., Schoebel J., Byrne J., Esiri M., Adams C. B., Wass J. A. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 1999 Aug;51(2):181–188. doi: 10.1046/j.1365-2265.1999.00754.x. [DOI] [PubMed] [Google Scholar]
- Ross J. R., Saunders Y., Edmonds P. M., Patel S., Broadley K. E., Johnston S. R. D. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003 Aug 30;327(7413):469–469. doi: 10.1136/bmj.327.7413.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson C. J., Cummings F., Chalmers J., Newton R. W. Abnormal insulin treatment behaviour: a major cause of ketoacidosis in the young adult. Diabet Med. 1995 May;12(5):429–432. doi: 10.1111/j.1464-5491.1995.tb00508.x. [DOI] [PubMed] [Google Scholar]
- Tietgens S. T., Leinung M. C. Thyroid storm. Med Clin North Am. 1995 Jan;79(1):169–184. doi: 10.1016/s0025-7125(16)30090-6. [DOI] [PubMed] [Google Scholar]
- Werbel S. S., Ober K. P. Pheochromocytoma. Update on diagnosis, localization, and management. Med Clin North Am. 1995 Jan;79(1):131–153. doi: 10.1016/s0025-7125(16)30088-8. [DOI] [PubMed] [Google Scholar]
- van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359–1367. doi: 10.1056/NEJMoa011300. [DOI] [PubMed] [Google Scholar]